Overview of the RegHealth-RI project


General Description

As shown in the last Regional Innovation Scoreboard published in 2014, the performance of the European regions varies from the most advanced regions or “innovation leaders” to the least ones or “modest innovators”. The new Research Framework Program ‘Horizon 2020’ (H2020) and Structural Funds (SF) are believed to be a trigger aimed at diminishing the gaps among EU regions.

In addition to these tools, some alternative and specific strategies can be addressed with the same aim of balancing these marked differences and providing solutions to achieve a smart, sustainable and inclusive growth of the regions as well as a better effectiveness of their research and development (R&D) and innovation policies. The RegHealth-RI project looks for new measures and actions to reduce the differences on the research and innovation (R&I) performance of the EU regions by focusing on the field of health since it is not just a value in itself but rather a driver for growth.


Project Objectives

The project will develop a multidisciplinary network formed by representatives of academic and R&D organisations, national and regional authorities,Horizon 2020 National Contact Points (NCPs) in health, companies, etc., to deal with the main problems affecting health research and innovation of EU regions. Many of these organizations have already showed their interest in participating as active members of the network.

The final goal of the RegHealth-RI project is to contribute in a significant way to three key Horizon 2020 goals, namely, (1) reducing the gaps in health R&I across the EU regions, (2) widening the participation in H2020 and (3) facilitating synergies between H2020 and Structural Funds by proposing new initiatives and concrete approaches to EU, national and regional policy- and decision-makers.

The project concrete objectives are the following:

  • Determining the State of the Art of the health Research and Innovation (R&I) activities in EU regions looking for key factors, specific differences and common patterns which could explain the differences between them.
  • Designing and developing indicators to measure the degree of development of the health R&I across the European regions.
  • Developing networking activities and promoting the dialogue between different actors involved in health R&I in Europe: academic and R&D organisations, RIS3 and other national and regional authorities, EC and other EU organizations, industry, health/biotech clusters, S&T parks, Horizon 2020 NCPs, etc., to promote the exchange of knowledge and expertise.
  • To discuss on the divide in European health R&I to bring possible remedial actions (three specific Workshops and the 1st European Conference on “Bridging the divide in European health R&I” will be organized).
  • Disseminating the project results: policy briefs, workshop reports and presentations, scientific articles, newsletters, etc., to the appropriate stakeholders, with a special focus to EC and regional decision-makers.